Treatment of severe Plasmodium falciparum malaria with quinidine gluconate: discontinuation of parenteral quinine from CDC drug service
- PMID: 1848916
Item in Clipboard
Treatment of severe Plasmodium falciparum malaria with quinidine gluconate: discontinuation of parenteral quinine from CDC drug service
MMWR Morb Mortal Wkly Rep.
.
Abstract
CDC has recently reviewed data on the reported incidence in the United States of Plasmodium falciparum malaria and has evaluated information on the effective management of severe life-threatening infections. As a result of this review, CDC has concluded that the drug of choice in the United States for treatment of complicated P. falciparum infections is parenteral quinidine gluconate. Therefore, effective immediately, parenteral quinine dihydrochloride will no longer be available from the CDC Drug Service.
Similar articles
-
Treatment with quinidine gluconate of persons with severe Plasmodium falciparum infection: discontinuation of parenteral quinine from CDC Drug Service.MMWR Recomm Rep. 1991 Apr 19;40(RR-4):21-3. MMWR Recomm Rep. 1991. PMID: 1850497
-
Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion.N Engl J Med. 1989 Jul 13;321(2):65-70. doi: 10.1056/NEJM198907133210201. N Engl J Med. 1989. PMID: 2659994
-
Treatment of chloroquine-resistant falciparum malaria with a combination of quinine, quinidine and cinchonine (LA40221) in adults by oral and intravenous administration.Acta Leiden. 1987;55:139-49. Acta Leiden. 1987. PMID: 3321829 No abstract available.
-
Intravenous artesunate for the treatment of severe malaria.Ann Pharmacother. 2010 Jul-Aug;44(7-8):1250-8. doi: 10.1345/aph.1M732. Epub 2010 Jun 15. Ann Pharmacother. 2010. PMID: 20551300 Review.
-
Therapeutics review: the use of parenteral drugs for falciparum malaria.Cent Afr J Med. 1990 Oct;36(10):259-63. Cent Afr J Med. 1990. PMID: 2092877 Review.
Cited by
-
Malaria: diagnosis and treatment of falciparum malaria in travelers during and after travel.Curr Infect Dis Rep. 2006 Jan;8(1):35-42. doi: 10.1007/s11908-006-0033-5. Curr Infect Dis Rep. 2006. PMID: 16448599
-
Pharmacokinetic justification of antiprotozoal therapy. A US perspective.Clin Pharmacokinet. 1991 Dec;21(6):479-93. doi: 10.2165/00003088-199121060-00007. Clin Pharmacokinet. 1991. PMID: 1782741 Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials